Related Experiment Video
Updated: Apr 18, 2026
07:56
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
18.6K
[Relationship between serum adiponectin and bone mineral density in preterm infants]
Tao Wang1, Ping-Yang Chen, Zi-Yan Zhao
1Division of Neonatology, Children's Medical Center, Second Xiangya Hospital of Central South University, Changsha 410011, China. wycpyfu@163.com.
Summary
Serum adiponectin levels are lower in preterm infants, correlating positively with bone mineral density. This suggests adiponectin may play a role in preterm infant bone development.
Area of Science:
- Neonatal Research
- Endocrinology
- Pediatric Bone Health
Context:
- Preterm infants face increased risks for developmental complications.
- Bone mineral density is a critical indicator of skeletal health in neonates.
- Adiponectin, an adipokine, is implicated in metabolic and inflammatory processes.
Purpose:
- To investigate serum adiponectin levels in preterm infants.
- To assess the relationship between serum adiponectin and bone mineral density (measured by tibia speed of sound) in preterm infants.
Summary:
- Serum adiponectin levels were significantly lower in early and late preterm infants compared to full-term infants.
- Tibia speed of sound, a marker of bone mineral density, was also reduced in preterm infants, particularly in the early preterm group.
- A positive correlation was found between serum adiponectin levels and tibia speed of sound in preterm infants, with both adiponectin and birth weight identified as independent predictors.
Impact:
- Findings suggest lower serum adiponectin in preterm infants may contribute to impaired bone development.
- Highlights the potential role of adiponectin as a biomarker for bone health in preterm neonates.
- Provides insights for potential future interventions targeting adiponectin to improve bone mineralization in vulnerable preterm populations.
Related Concept Videos
01:29Bone Disorders
8.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.8K
01:17Hormones and Bone Tissue
4.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
450
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
450
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
513
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
01:09Changes in the Appendicular Skeleton with Age
4.1K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
4.1K